Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

100620

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how the Secretary of State for Health has discharged his duty to report on the treatment of National Health Service health care providers as specified in section 8 of the Health and Social Care Act 2012.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL2351
	answer	answer is ministerial correction date of answer 31/10/2014 answer text <p>The Secretary of State commissioned Monitor to lead a Fair Playing Field Review into the equal treatment of providers of National Health Service services. The Review published its final Report in March 2013. Since publication, Monitor has established a high level implementation group, of which the Department is a member, to take forward the Review’s recommendations.</p><p> </p><p><strong> </strong></p><p> </p><p>As part of its annual assurance processes the Department seeks confirmation from all its Directors General that they and our Arm’s Length Bodies have taken the duty into consideration, as outlined in Section 8 of the Health and Social Care Act 2012.</p><p> </p> answering member printed Earl Howe question first answered 31/10/2014 13:18:46 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

100623

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Cost Effectiveness
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether the "Nicholson Challenge" still operates within the National Health Service; if so, what efficiency savings have been identified to date; and, if not, why not.
	tabling member printed	Lord Sharkey
	uin	HL2354
	answer	answer is ministerial correction date of answer 30/10/2014 answer text <p>The 2010 Spending Review protected health funding in real terms. However, in order to continue to meet rising demands while improving services, it was estimated that up to £20 billion of efficiency savings would be required over the four years from 2011-12 to 2014-15.</p><p> </p><p> </p><p> </p><p>The National Health Service response to this challenge was organised through the Quality, Innovation, Productivity and Prevention (QIPP) initiative, also known colloquially as the ‘Nicholson challenge’ after Sir David Nicholson, who was Chief Executive of the NHS at the time that QIPP originated.</p><p> </p><p> </p><p> </p><p>The NHS is on track to deliver up to £20 billion efficiency savings, having reported around £15 billion of efficiencies in the first three years, all of which will be reinvested into frontline care.</p><p> </p> answering member printed Earl Howe question first answered 30/10/2014 12:11:13 answering member 2000 label Biography information for Earl Howe
	tabling member	4196 label Biography information for Lord Sharkey

100642

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Transatlantic Trade and Investment Partnership
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they have undertaken an impact assessment of the potential impacts on the National Health Service of the Transatlantic Trade and Investment Partnership which is being negotiated between the European Union and the United States.
	tabling member printed	Baroness Manzoor
	uin	HL2373
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The Transatlantic Trade and Investment Partnership (TTIP) will not affect the way the United Kingdom Government runs the National Health Service. It has been made clear by negotiators from both the United States and the European Union that it is up to the UK alone to decide how the NHS is run and any assertion that TTIP will undermine the Government’s control of the NHS is a red herring.</p><p> </p><p> </p><p> </p><p>The TTIP could offer great benefits to British business and for British jobs. Greater consistency in existing and new regulatory requirements would make it easier for companies - especially small and medium enterprises - to access markets and, for patients, potentially help to increase access to new medicines and medical devices.</p><p> </p> answering member printed Earl Howe grouped question UIN HL2374 HL2375 question first answered 29/10/2014 12:27:46 answering member 2000 label Biography information for Earl Howe
	tabling member	4289 label Biography information for Baroness Manzoor

100643

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Transatlantic Trade and Investment Partnership
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what are the implications for the National Health Service and the staff who work in the National Health Service if the Transatlantic Trade and Investment Partnership is agreed.
	tabling member printed	Baroness Manzoor
	uin	HL2374
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The Transatlantic Trade and Investment Partnership (TTIP) will not affect the way the United Kingdom Government runs the National Health Service. It has been made clear by negotiators from both the United States and the European Union that it is up to the UK alone to decide how the NHS is run and any assertion that TTIP will undermine the Government’s control of the NHS is a red herring.</p><p> </p><p> </p><p> </p><p>The TTIP could offer great benefits to British business and for British jobs. Greater consistency in existing and new regulatory requirements would make it easier for companies - especially small and medium enterprises - to access markets and, for patients, potentially help to increase access to new medicines and medical devices.</p><p> </p> answering member printed Earl Howe grouped question UIN HL2373 HL2375 question first answered 29/10/2014 12:27:47 answering member 2000 label Biography information for Earl Howe
	tabling member	4289 label Biography information for Baroness Manzoor

100644

	registered interest
	date	23/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Transatlantic Trade and Investment Partnership
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what are the implications for hospitals and foundation trusts if the Transatlantic Trade and Investment Partnership is agreed.
	tabling member printed	Baroness Manzoor
	uin	HL2375
	answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The Transatlantic Trade and Investment Partnership (TTIP) will not affect the way the United Kingdom Government runs the National Health Service. It has been made clear by negotiators from both the United States and the European Union that it is up to the UK alone to decide how the NHS is run and any assertion that TTIP will undermine the Government’s control of the NHS is a red herring.</p><p> </p><p> </p><p> </p><p>The TTIP could offer great benefits to British business and for British jobs. Greater consistency in existing and new regulatory requirements would make it easier for companies - especially small and medium enterprises - to access markets and, for patients, potentially help to increase access to new medicines and medical devices.</p><p> </p> answering member printed Earl Howe grouped question UIN HL2373 HL2374 question first answered 29/10/2014 12:27:46 answering member 2000 label Biography information for Earl Howe
	tabling member	4289 label Biography information for Baroness Manzoor